Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Biora Therapeutics, Inc. (PROG) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Biora Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1580063.
Total stock buying since 2020: $172,416,493.
Total stock sales since 2020: $4,585.
Total stock option exercises since 2020: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2022 | 0 | $0 | 7,517 | $4,585 | 0 | $0 |
| 2021 | 17,462,447 | $43,626,808 | 0 | $0 | 0 | $0 |
| 2020 | 15,270,985 | $128,789,685 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2022-07 | 0 | $0 | 7,517 | $4,585 | 0 | $0 |
| 2021-06 | 17,462,447 | $43,626,808 | 0 | $0 | 0 | $0 |
| 2020-12 | 8,551,736 | $28,121,213 | 0 | $0 | 0 | $0 |
| 2020-09 | 9,250 | $79,087 | 0 | $0 | 0 | $0 |
| 2020-08 | 10,000 | $89,400 | 0 | $0 | 0 | $0 |
| 2020-06 | 6,699,999 | $100,499,985 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-07-05 | Sarna Surbhi (Director) | Sale | 7,517 | .61 | 4,585 |
| 2021-06-14 | Athyrium Opportunities Associates Lp (10% Owner) | Buy | 8,097,166 | 2.47 | 20,000,000 |
| 2021-06-14 | Nb Alternatives Gp Holdings Llc (10% Owner) | Buy | 8,097,166 | 2.47 | 20,000,000 |
| 2021-06-01 | Nb Alternatives Gp Holdings Llc (10% Owner) | Buy | 1,268,115 | 2.86 | 3,626,808 |
| 2020-12-16 | Silvestry Damon (Chief Operating Officer) | Buy | 58,081 | 4.55 | 264,268 |
| 2020-12-15 | Silvestry Damon (Chief Operating Officer) | Buy | 63,870 | 4.07 | 259,950 |
| 2020-12-14 | Alter Jeffrey D. (Director) | Buy | 20,000 | 4.85 | 97,000 |
| 2020-12-07 | Athyrium Opportunities Associates Lp (10% Owner) | Buy | 4,128,440 | 3.27 | 13,499,998 |
| 2020-12-07 | Nb Alternatives Gp Holdings Llc (10% Owner) | Buy | 4,128,440 | 3.27 | 13,499,998 |
| 2020-12-02 | Stylli Harry (Chairman & CEO) | Buy | 152,905 | 3.27 | 499,999 |
| 2020-09-03 | Cooper Matthew T (Chief Scientific Officer) | Buy | 9,151 | 8.55 | 78,241 |
| 2020-09-02 | Cooper Matthew T (Chief Scientific Officer) | Buy | 99 | 8.55 | 846 |
| 2020-08-19 | Stylli Harry (Chairman & CEO) | Buy | 10,000 | 8.94 | 89,400 |
| 2020-06-23 | Nb Alternatives Holdings Llc (10% Owner) | Buy | 3,333,333 | 15.00 | 49,999,995 |
| 2020-06-23 | Athyrium Opportunities Associates Lp (10% Owner) | Buy | 3,333,333 | 15.00 | 49,999,995 |
| 2020-06-19 | Stylli Harry (Chairman & CEO) | Buy | 33,333 | 15.00 | 499,995 |
Insider trading activities including stock purchases, stock sales, and option exercises of PROG listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Biora Therapeutics, Inc. (symbol PROG, CIK number 1580063) see the Securities and Exchange Commission (SEC) website.